Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Report of a WHO Consultation on Traditional Medicine and AIDS: Clinical Evaluation of Traditional Medicines and Natural Products (Geneva, 26-28 September 1990)
(1990; 20 pages) View the PDF document
Table of Contents
View the document1. Introduction
View the document2. Background information
View the document3. Preclinical considerations
View the document4. Clinical considerations
View the document5. Recommendations
View the documentAnnex 1. List of participants
View the documentAnnex 2. Guidelines for clinical trials with traditional medicine products used in the treatment of AIDS and AIDS-related diseases
View the documentAnnex 3. Proposed who clinical staging system for HIV infection and disease1
 

Annex 1. List of participants

Dr D.V.C. Awang, Natural Products Section, Bureau of Drug Research, Health, Protection Branch, Health and Welfare Canada, Tunney’s Pasture, Ottawa, Canada (Rapporteur)

Dr Ding Guang-Sheng, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai, People’s Republic of China

Dr N.R. Farnsworth, University of Illinois at Chicago, College of Pharmacy, Chicago, USA

Dr B.B. Gaitonde, Goa Medical College, Goa,, India (Rapporteur)

Dr P. Goldman, Food and Drug Laboratory, Department of Nutrition, Harvard University School of Public Health, Boston, USA (Chairman)

Dr Y. Mizoguchi, The Third Department of Internal Medicine, Osaka City, University Medical School, Osaka, Japan

Dr R.D. Mugerwa, Head, Department of Medicine, Medical School, Makerere University, Kampala, Uganda

Dr A. Salako, Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria

Dr R. Samtleben, Institute for Pharmaceutical Biology, University of Munich, Germany

Dr D.P. Waller, Department of Pharmacodynamics, University of Illinois at Chicago, College of Pharmacy, Chicago, USA

WHO Secretariat

Dr Hu Ching-Li, Assistant Director-General

Dr O. Akerele, Programme Manager, Traditional Medicine Programme, Division of Drug Management and Policies (Secretary)

Dr M. Couper, Medical Officer, Pharmaceuticals, Division of Drug Management and Policies

Dr P. Crocchiolo, Consultant, Clinical Research and Drug Development, Office of Research, Global Programme on AIDS

Dr J. Esparza, Acting Chief, Vaccine Development, Office of Research, Global Programme on AIDS

Mrs M. Helling-Borda, Senior Scientist, Action Programme on Essential Drugs, Division of Drug Management and Policies

Dr D.L. Heymann, Acting Chief, Office of Research, Global Programme on AIDS

Dr M.V. Karam, Acting Chief, Clinical Research and Drug Development, Office of Research, Global Programme on AIDS

Ms Maruyama, Associate Technical Officer, Traditional Medicine Programme, Division of Drug Management and Policies

Dr M.H. Merson, Director, Global Programme on AIDS

Ms G. Pinet, Senior Legal Officer, Office of the Legal Counsel

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014